U.S. markets closed

BETTER PLANT SCIENCES INC (YG3.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
0.04000.0000 (0.00%)
At close: 8:30AM CET
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0400
Open0.0400
Bid0.0360 x 0
Ask0.0495 x 0
Day's Range0.0400 - 0.0400
52 Week Range0.0400 - 0.2150
Volume4,000
Avg. Volume93
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Better Plant Launches Urban Juve Loyalty Program with LoyaltyLion
      Newsfile

      Better Plant Launches Urban Juve Loyalty Program with LoyaltyLion

      Vancouver, British Columbia--(Newsfile Corp. - November 24, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") or (the "Company") is pleased to announce the launch of a customer rewards program called "Insider Rewards" for its Urban Juve skin care line. Better Plant Launches Urban Juve Loyalty Program with LoyaltyLionTo view an enhanced version of this image, please visit:https://orders.newsfilecorp.com/files/6377/68816_d5e319fef42e2b1a_001full.jpg"Insider Rewards will give our customers the opportunity to collect points ...

    • NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss
      Newsfile

      NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss

      Vancouver, British Columbia--(Newsfile Corp. - November 19, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") or (the "Company") is pleased to announce that its majority owned subsidiary NeonMind Biosciences Inc. ("NeonMind") has now commenced a psilocybin preclinical trial examining psilocybin as a potential treatment to promote and cause weight loss and to reduce food cravings (the "Trial") after obtaining Health Canada approval. The Trial is being conducted by ...

    • Newsfile

      Psilocybin Could Unlock Key Mental Health Treatments for Millions of People

      Houston, Texas--(Newsfile Corp. - November 18, 2020) - Psilocybin could be the key to unlocking key treatments for mental health issues. "Existing antidepressant drugs don't work well for an estimated 30 to 50 percent of the people who try them; when they do work, the effects can take weeks to kick in. Psilocybin, a compound that can profoundly alter consciousness and perceptions of reality, might be a powerful alternative, says Roland Griffiths, a neuropsychopharmacologist ...